FORM DEF 14A

Company

ADC Therapeutics SA

Filed

September 23, 2024

Period of Report

November 11, 2024

Accession Number

0000950103-24-013848

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →